BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22996131)

  • 1. Monogenic models: what have the single gene disorders taught us?
    Klupa T; Skupien J; Malecki MT
    Curr Diab Rep; 2012 Dec; 12(6):659-66. PubMed ID: 22996131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.
    Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
    Diabetes Metab Syndr; 2012; 6(1):54-8. PubMed ID: 23014256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous ABCC8 mutations are a cause of MODY.
    Bowman P; Flanagan SE; Edghill EL; Damhuis A; Shepherd MH; Paisey R; Hattersley AT; Ellard S
    Diabetologia; 2012 Jan; 55(1):123-7. PubMed ID: 21989597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.
    Oztekin O; Durmaz E; Kalay S; Flanagan SE; Ellard S; Bircan I
    J Perinatol; 2012 Aug; 32(8):645-7. PubMed ID: 22842804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monogenic Forms of Diabetes Mellitus.
    Gaál Z; Balogh I
    Exp Suppl; 2019; 111():385-416. PubMed ID: 31588541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Permanent neonatal diabetes with known genetic background: oral drugs in treatment of childhood diabetes].
    Gach A; Gadzicka A; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2008; 14(1):45-9. PubMed ID: 18577347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes.
    Hartemann-Heurtier A; Simon A; Bellanné-Chantelot C; Reynaud R; Cavé H; Polak M; Vaxillaire M; Grimaldi A
    Diabetes Metab; 2009 Jun; 35(3):233-5. PubMed ID: 19342262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pathway to insulin independence in newborns and infants with diabetes.
    Shahawy S; Chan NK; Ellard S; Young E; Shahawy H; Mace J; Peverini R; Chinnock R; Njolstad PR; Hattersley AT; Hathout E
    J Perinatol; 2011 Aug; 31(8):567-70. PubMed ID: 21796147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
    Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
    Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of single nucleotide polymorphisms in K(ATP) channel genes on type 2 diabetes in a Turkish population.
    Gonen MS; Arikoglu H; Erkoc Kaya D; Ozdemir H; Ipekci SH; Arslan A; Kayis SA; Gogebakan B
    Arch Med Res; 2012 May; 43(4):317-23. PubMed ID: 22704848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient neonatal diabetes due to activating mutation in the ABCC8 gene encoding SUR1.
    Batra CM; Gupta N; Atwal G; Gupta V
    Indian J Pediatr; 2009 Nov; 76(11):1169-72. PubMed ID: 20092027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations.
    Riveline JP; Rousseau E; Reznik Y; Fetita S; Philippe J; Dechaume A; Hartemann A; Polak M; Petit C; Charpentier G; Gautier JF; Froguel P; Vaxillaire M
    Diabetes Care; 2012 Feb; 35(2):248-51. PubMed ID: 22210575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.
    Jahnavi S; Poovazhagi V; Mohan V; Bodhini D; Raghupathy P; Amutha A; Suresh Kumar P; Adhikari P; Shriraam M; Kaur T; Das AK; Molnes J; Njolstad PR; Unnikrishnan R; Radha V
    Clin Genet; 2013 May; 83(5):439-45. PubMed ID: 22831748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
    Sperling MA
    N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic causes and treatment of neonatal diabetes and early childhood diabetes.
    Barbetti F; D'Annunzio G
    Best Pract Res Clin Endocrinol Metab; 2018 Aug; 32(4):575-591. PubMed ID: 30086875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment of diabetes caused by activating ABCC8/SUR1 mutation with glimepiride.
    Karges B; Schnur D; Ellard S; Kentrup H; Karges W
    Diabet Med; 2012 May; 29(5):692-3. PubMed ID: 21992555
    [No Abstract]   [Full Text] [Related]  

  • 17. [Three-year observation of permanent neonatal diabetes].
    Noczyńska A; Zubkiewicz-Kucharska A; Salmonowicz B; Małecki M; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):50-4. PubMed ID: 20529607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.
    Greeley SA; Naylor RN; Philipson LH; Bell GI
    Curr Diab Rep; 2011 Dec; 11(6):519-32. PubMed ID: 21993633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation.
    Zwaveling-Soonawala N; Hagebeuk EE; Slingerland AS; Ris-Stalpers C; Vulsma T; van Trotsenburg AS
    Diabetologia; 2011 Feb; 54(2):469-71. PubMed ID: 21109997
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; Kahn SE; Franks PW; Dabelea D; Hamman RF; Knowler WC; Nathan DM; Altshuler D
    Diabetes; 2007 Feb; 56(2):531-6. PubMed ID: 17259403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.